New Rochelle, United States
Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization. Your Free GEN Subscription:
3
Total Investments
2
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Biotechnology
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About BrightGene
Recent Investments (3)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Jul 2020 | |
| Series A | •••••• | Jul 2019 | |
| Seed Round | •••••• | Aug 2018 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
